| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/20/2013 | WO2013058630A3 Composition containing stereocalpin a as a novel compound for preventing or treating arteriosclerosis |
| 06/20/2013 | WO2013058527A3 Combined formulation of leukotriene antagonist and epinastine |
| 06/20/2013 | WO2013057741A3 Pharmaceutical compositions of ursodeoxycholic acid |
| 06/20/2013 | WO2013057013A3 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 06/20/2013 | WO2013056142A3 Meso-biliverdin compositions and methods |
| 06/20/2013 | WO2013056003A3 Catechol diethers as potent anti-hiv agents |
| 06/20/2013 | WO2013052943A3 Small molecule inhibitors of mcl-1 and uses thereof |
| 06/20/2013 | WO2013052736A9 Methods of treating or preventing blood loss during surgery using the serine protease inhibitor mdco-2010 |
| 06/20/2013 | WO2013052263A3 Antifungal compounds |
| 06/20/2013 | WO2013045380A3 Pharmaceutically acceptable mglur5 positive allosteric modulators and their methods of identification |
| 06/20/2013 | WO2013042065A3 Inhibitors of type ii ribosome inactivating proteins |
| 06/20/2013 | WO2013033268A3 Bivalent bromodomain ligands, and methods of using same |
| 06/20/2013 | WO2013032744A3 Compositions and methods for increasing desirable microbiota |
| 06/20/2013 | WO2013020164A9 Compounds for treating respiratory syncytial virus infections |
| 06/20/2013 | WO2013007725A3 Aliskiren hemifumarate, crystal form and amorphous solid |
| 06/20/2013 | WO2012068299A9 Cbp/catenin antagonists for enhancing asymmetric division of somatic stem cells |
| 06/20/2013 | WO2012068274A8 Treatment of type ii diabetes and diabetes-associated diseases with safe chemical mitochondrial uncouplers |
| 06/20/2013 | WO2012034201A3 Creatine-containing food supplement composition, method for preparing same and food supplement dosage form |
| 06/20/2013 | US20130158589 Methods And Kits For Treating Lacerations And Puncture Wounds Using Inverse Thermosensitive Polymers |
| 06/20/2013 | US20130158362 Methods for treating hyperbilirubinemia with stannsoporfin |
| 06/20/2013 | US20130158234 Specific binding agents of human angiopoietin-2 |
| 06/20/2013 | US20130158232 Method for selecting a candidate drug compound |
| 06/20/2013 | US20130158129 Natural, multiple release and re-use compositions |
| 06/20/2013 | US20130158127 Tea tree oil derivatives |
| 06/20/2013 | US20130158125 Treatment of CNS Disorders with trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine |
| 06/20/2013 | US20130158124 1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases |
| 06/20/2013 | US20130158123 Method of treating non-alcoholic fatty liver disease and steatohepatitis |
| 06/20/2013 | US20130158122 EP2 Agonist from Non-Prostanoid Structures Designed as PGE2 Antagonists |
| 06/20/2013 | US20130158121 Methods for treating vasomotor symptoms using gaba analogs in a gastric retentive dosage form |
| 06/20/2013 | US20130158119 Pharmaceutical semi-solid composition of isotretinoin |
| 06/20/2013 | US20130158113 Methods and compositions for treating brain cancer |
| 06/20/2013 | US20130158111 Compositions and Methods for Depleting Mutant p53 |
| 06/20/2013 | US20130158110 Therapeutic compositions |
| 06/20/2013 | US20130158109 Rhenium complexes and their pharmaceutical use |
| 06/20/2013 | US20130158108 Uses of n-butylidenephthalide in treating a liver injury and improving liver function |
| 06/20/2013 | US20130158107 Novel flavonoids and uses thereof |
| 06/20/2013 | US20130158101 Regulators of nfat and/or store-operated calcium entry |
| 06/20/2013 | US20130158100 Intracellular dna receptor |
| 06/20/2013 | US20130158099 Methods for Identifying Agents that Inhibit Cell Migration, Promote Cell Adhesion and Prevent Metastasis |
| 06/20/2013 | US20130158098 Alkenyl Substituted Cycloaliphatic Compounds as Chemical Inducers of Proximity |
| 06/20/2013 | US20130158095 Eml4-alk fusion gene |
| 06/20/2013 | US20130158092 New Oral Formulation |
| 06/20/2013 | US20130158089 MANUFACTURE, COMPOSITIONS AND USES OF COAGULATION FACTOR VIIa MODULATOR |
| 06/20/2013 | US20130158088 Treatment of hypertension and/or prevention or treatment of heart failure in a mammal receiving anti-coagulant therapy |
| 06/20/2013 | US20130158086 Methods of treatment and pharmaceutical composition |
| 06/20/2013 | US20130158085 Methods of treatment and pharmaceutical composition |
| 06/20/2013 | US20130158084 Pharmaceutical Composition Comprising Losartin For Treating or Preventing Statin BasedGrug-Induced Muscle Toxicity |
| 06/20/2013 | US20130158080 Methods for treating hypertension in black patients |
| 06/20/2013 | US20130158079 Clevidipine emulsion formulations containing antimicrobial agents |
| 06/20/2013 | US20130158078 Heterocyclic Sulfone MGLUR4 Allosteric Potentiators, Compositions, and Methods of Treating Neurological Dysfunction |
| 06/20/2013 | US20130158077 Pharmaceutical compositions |
| 06/20/2013 | US20130158076 Methylene Urea Derivatives |
| 06/20/2013 | US20130158074 Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain |
| 06/20/2013 | US20130158073 Methods Of Diminishing Co-Abuse Potential |
| 06/20/2013 | US20130158072 Kappa opioid receptor binding ligands |
| 06/20/2013 | US20130158071 Pharmaceutical compositions and administrations thereof |
| 06/20/2013 | US20130158069 Preventive and/or therapeutic agent for thromboembolism in thromboembolism patient with severe renal impairment |
| 06/20/2013 | US20130158067 TRPV1 Antagonists |
| 06/20/2013 | US20130158064 Novel iso-ergoline derivatives |
| 06/20/2013 | US20130158062 Multi-arm polymer prodrugs |
| 06/20/2013 | US20130158061 Controlled release hydrocodone |
| 06/20/2013 | US20130158060 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists |
| 06/20/2013 | US20130158058 Hypercholesterolemia and tendinous injuries |
| 06/20/2013 | US20130158055 Prevention Of Pancreatic Beta Cell Degeneration |
| 06/20/2013 | US20130158039 N-((1r,2s,5r)-5-(tert-butylamino)-2-((s)-3-(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes |
| 06/20/2013 | US20130158036 N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors |
| 06/20/2013 | US20130158035 Antimetastatic compounds |
| 06/20/2013 | US20130158033 Use of sigma ligands in opioid-induced hyperalgesia |
| 06/20/2013 | US20130158028 Use of stimulators and activators of soluble guanylate cyclase for treating sickle-cell anemia and conserving blood substitutes |
| 06/20/2013 | US20130158027 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 06/20/2013 | US20130158026 Chromenone derivatives |
| 06/20/2013 | US20130158023 Identification of gene expression as a predictive biomarker for lkb1 status |
| 06/20/2013 | US20130158020 Indazole derivatives useful as erk inhibitors |
| 06/20/2013 | US20130158016 Anesthetic association, anesthetic composition, and anesthetic medicament for veterinary use |
| 06/20/2013 | US20130158014 Method for treating diseases associated with alterations in cellular integrity using rho kinase inhibitor compounds |
| 06/20/2013 | US20130158013 Processes for the preparation of 5-ht2c receptor agonists |
| 06/20/2013 | US20130158012 Use and composition for treating dementia |
| 06/20/2013 | US20130158010 Methods for increasing the stabilization of hypoxia inducible factor-1 alpha |
| 06/20/2013 | US20130158008 Solid ivabradine-containing composition |
| 06/20/2013 | US20130157994 High-purity texaphyrin metal complexes |
| 06/20/2013 | US20130157990 Method of drug detoxification |
| 06/20/2013 | US20130157989 7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof |
| 06/20/2013 | US20130157988 Substituted androst-4-ene diones |
| 06/20/2013 | US20130157987 1-deoxy analogs of 1,25-dihydroxyvitamin d3 compounds |
| 06/20/2013 | US20130157986 Novel methylenedioxy phenolic compounds and their use to treat disease |
| 06/20/2013 | US20130157985 Pain relief compositions, manufacture and uses |
| 06/20/2013 | US20130157983 Compounds for Use in the Treatment of Cancer |
| 06/20/2013 | US20130157981 Heterocyclic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof |
| 06/20/2013 | US20130157980 Substituted indole derivatives |
| 06/20/2013 | US20130157979 Phosphate esters of gyrase and topoisomerase inhibitors |
| 06/20/2013 | US20130157978 Preparation for the prevention and/or treatment of vascular disorders |
| 06/20/2013 | US20130157976 Novel pyridopyrazines and their use as modulators of kinases |
| 06/20/2013 | US20130157975 Agent for suppressing elevation of blood alcohol concentration |
| 06/20/2013 | US20130157974 Preparation Comprising Iron(III) Complex Compounds And Redox-Active Substance(s) |
| 06/20/2013 | US20130157973 Pharmaceutical compositions and methods for treating gastrointestinal infections and disorders |
| 06/20/2013 | US20130157972 Compositions including triciribine and bortezomib and derivatives thereof and methods of use thereof |
| 06/20/2013 | US20130157971 2'-fluoronucleosides |
| 06/20/2013 | US20130157970 Novel glycoside compounds |
| 06/20/2013 | US20130157967 Use Of A Phospholipid-Containing Composition For The Removal Of Subcutaneous Fat Accumulations By Subcutaneous Lipolysis |
| 06/20/2013 | US20130157966 New use of icariin and epimedium flavonoids containing icariin |